Modafinil
NDC 55253-801, Modafinil, tablet, from CIMA LABS INC..
- Product NDC
- 55253-801
- Status
- Listed
- Labeler
- CIMA LABS INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA020717
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/55253-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MODAFINIL100 mg/1
Pharmacologic classes
Central Nervous System Stimulation [PE]; Increased Sympathetic Activity [PE]; Sympathomimetic-like Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55253-801-30 | 55253080130 | 30 TABLET in 1 BOTTLE (55253-801-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9f3b0bd2-72a3-411f-aeec-b533373f1a97NADAC price for package 55253080130
GET /v1/drugs/nadac/55253080130
Use it
Look up 55253-801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55253-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55253-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.